# Step Count and Treatment Response in Neoadjuvant Breast Cancer

> **NCT07162675** · — · RECRUITING · sponsor: **Ankara Etlik City Hospital** · enrollment: 82 (estimated)

## Conditions studied

- Breast Neoplasm Malignant Female
- Exercise
- Breast Cancer Females
- Wearable Technology
- Sleep Quality
- Smartwatches

## Interventions

- **DEVICE:** Huawei Fit 2 Smartwatch

## Key facts

- **NCT ID:** NCT07162675
- **Lead sponsor:** Ankara Etlik City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-08
- **Primary completion:** 2026-08-29
- **Final completion:** 2026-08-29
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07162675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07162675, "Step Count and Treatment Response in Neoadjuvant Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07162675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*